Skip to main content Deutsch

Overview current studies

Drug trial for weight loss ‘Diabetes type 2’

A new drug is currently being tested for its effect on type 2 diabetes patients. Our team is evaluating the effect on weight, blood glucose levels, liver fat content and glycogen (stored glucose).

We are looking for participants (m/f/d):

  • Age: between 18 and 65 years,
  • Previous illness: type 2 diabetes
  • Overweight (BMI 27 to 39.9)
  • Non-smokers

Participation is not possible with:

  • active insulin therapy
  • Taking more than 2 other medications for diabetes in tablet form
  • Severe vascular disease
  • Type 1 diabetes
  • Cancer diagnosis in the last 10 years (exception: light skin cancer)
  • Use of preparations for weight reduction
  • Contraindications for MRT

Duration of treatment: 25 weeks
Your expenses will be financially compensated